After approval, they need to ramp up to commercial scale, producing millions of doses per month instead of thousands
mRNA therapeutics require lipid nanoparticle (LNP) formulation capability, with the Moderna and BioNTech/Pfizer vaccine programs having demonstrated that LNP encapsulation is technically demanding, IP-rich (Arbutus Biopharma and Genevant Sciences control key ionizable lipid patents that were the subject of litigation with Moderna), and sensitive to process parameters that affect particle size, encapsulation efficiency, and in vivo transfection activity
Taurus Ganesha says it will prove to be a positive day for you, Taurus
Patient Safety: Healthcare providers have an ethical obligation to prioritize patient safety
She does, however, warn patients to watch out for signs of something more serious, like gall bladder problems or pancreatitis
Dietz, 2011)